Oncology PracticeStudy supports need for less toxic therapies in FLJanuary 16, 2019Follicular LymphomaIndolent Lymphoma
Hematology NewsFDA approves rituximab biosimilar for lymphomaNovember 28, 2018Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsRituximab biosimilar looks equivalent in follicular lymphomaNovember 19, 2018Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsR-CHOP looks viable as first line in follicular lymphomaNovember 15, 2018Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular LymphomaB Cell Lymphoma
Hematology NewsBortezomib may unlock resistance in WM with mutationsNovember 15, 2018Indolent LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsConsider treatment, testing when CLL symptoms emergeNovember 13, 2018CLLLeukemia, Myelodysplasia, TransplantationIndolent Lymphoma
Hematology NewsCLL: The initial work-upNovember 13, 2018CLLIndolent LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsZanubrutinib looks ‘robust’ in Waldenström macroglobulinemiaNovember 8, 2018Indolent Lymphoma
Hematology NewsVariant not linked to CLL in Southeast EuropeNovember 7, 2018CLLIndolent LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology NewsSandoz halts pursuit of U.S. approval for rituximab biosimilarNovember 5, 2018CLLLymphoma & Plasma Cell DisordersIndolent LymphomaFollicular LymphomaB Cell Lymphoma
Hematology NewsIbrutinib discontinuation harms survival in CLLOctober 18, 2018CLLMantle Cell LymphomaIndolent LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsIbrutinib plus obinutuzumab gets priority review in CLL/SLLOctober 17, 2018CLLIndolent LymphomaLeukemia, Myelodysplasia, TransplantationImmuno-oncology
Hematology NewsUpdated ThroLy system predicts need for thromboprophylaxisOctober 11, 2018ThrombosisLymphoma & Plasma Cell DisordersAggressive LymphomasIndolent Lymphoma
Hematology NewsSome mutation testing can be useful at CLL diagnosisOctober 5, 2018CLLLeukemia, Myelodysplasia, TransplantationIndolent LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsFrontline rituximab shows long-term success in indolent lymphomaOctober 5, 2018Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
